Compounds > dihydroalprenolol
Page last updated: 2024-08-23

dihydroalprenolol and Prostatic Neoplasms

dihydroalprenolol has been researched along with Prostatic Neoplasms in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Arias-Montaño, JA; Camacho, J; López-Colombo, A; Ramos-Jiménez, J; Reyes-Esparza, JA; Soria-Jasso, LE1

Other Studies

1 other study(ies) available for dihydroalprenolol and Prostatic Neoplasms

ArticleYear
Histamine augments beta2-adrenoceptor-induced cyclic AMP accumulation in human prostate cancer cells DU-145 independently of known histamine receptors.
    Biochemical pharmacology, 2007, Mar-15, Volume: 73, Issue:6

    Topics: Cell Line, Tumor; Cyclic AMP; Dihydroalprenolol; Histamine; Humans; Isoproterenol; Male; Prostatic Neoplasms; Receptors, Adrenergic, beta-2; Receptors, Histamine; Zinc

2007